Table 4a.
Hazard ratios for melanoma for some variables (BRCA1 subjects)
Variables | Controls/ cases | Univariate HR (95%CI) P-value |
Multivariate HR (95%CI) P-value |
---|---|---|---|
Age at baseline in years | |||
<=40 | 1237/5 | 1 | 1 |
41–50 | 1099/10 | 2.40 (0.82, 7.03) 0.11 | 1.90(0.63, 5.73) 0.26 |
>=51 | 1264/8 | 1.80 (0.59, 5.51) 0.30 | 1.47(0.46, 4.73) 0.52 |
Breast cancer at baseline | |||
No | 1969/10 | 1 | 1 |
Yes | 1629/13 | 1.72 (0.76, 3.93) 0.20 | 1.61 (0.66, 3.92) 0.30 |
Hormone replacement therapy | |||
No | 2300/11 | 1 | 1 |
Yes | 1299/12 | 1.65 (0.73, 3.74) 0.23 | 1.62 (0.68, 3.85) 0.28 |
Melanoma at baseline | |||
No | 3481/20 | 1 | 1 |
Yes | 28/2 | 11.9 (2.78, 50.9) 0.0008 | 9.45 (2.16, 41.3) 0.003 |
Family history of melanoma | |||
No | 1406/13 | 1 | 1 |
Yes, melanoma | 9/0 | 0 | 0 |
Country | |||
Canada | 1610/7 | 1 | 1 |
USA | 1990/16 | 2.41 (1.00, 5.93) 0.05 | 1.26 (0.35–4.58) 0.73 |